Metacrine Completes $22M Series B Financing | #VentureCanvas

FinSMEs | FinSMEs


Metacrine, Inc., a San Diego, CA-based innovative biotechnology company focused on drug development, closed a $22M Series B financing. The round, which brought total funding to approximately $60M since it began operations in early 2015, was led by new investor New Enterprise Associates (NEA), with participation from existing investors ARCH, Polaris, venBio, and Alexandria Venture […]

Continue reading …


Source: Metacrine Completes $22M Series B Financing